Mink Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,884,612 | -45 | -53 | |
EBITDA | -2,161 | -1,821 | -2,856 | -3,776 |
EBIT | -2,214 | -1,884 | -2,901 | -3,829 |
Net Income | -2,463 | -1,806 | -2,701 | -3,813 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,727 | -2,994 | -2,290 | -2,542 |
Cash | 4,577 | 6,328 | 9,313 | 5,817 |
Basic Shares | 37,733 | 39,533 | 37,142 | 34,642 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $2,704,743 | $0 |
Gross Profit | -204 | -28,244,535 | -28,358,591 | |
EBITDA | -22,253 | -30,827 | -27,703 | |
EBIT | -22,457 | -30,949 | -27,781 | |
Net Income | -10,784,802 | -22,457 | -24,779 | -23,114 |
Net Change In Cash | 0 | 0 | 2,704,743 | 0 |
Cost of Revenue | -19,272 | |||
Free Cash Flow | -9,555,476 | -15,836 | -19,116 | -13,076 |
Cash | 4,577 | 3,367 | 19,635 | 38,888 |
Basic Shares | 37,733 | 34,359 | 33,672 | 33,476 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.62 |
2024-09-30 | -$0.50 |
2024-06-30 | -$0.07 |
2024-03-31 | -$0.11 |
